Your browser doesn't support javascript.
loading
Crystal structure validation of verinurad via proton-detected ultra-fast MAS NMR and machine learning.
Torodii, Daria; Holmes, Jacob B; Moutzouri, Pinelopi; Nilsson Lill, Sten O; Cordova, Manuel; Pinon, Arthur C; Grohe, Kristof; Wegner, Sebastian; Putra, Okky Dwichandra; Norberg, Stefan; Welinder, Anette; Schantz, Staffan; Emsley, Lyndon.
Afiliação
  • Torodii D; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. lyndon.emsley@epfl.ch.
  • Holmes JB; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. lyndon.emsley@epfl.ch.
  • Moutzouri P; National Centre for Computational Design and Discovery of Novel Materials MARVEL, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Nilsson Lill SO; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. lyndon.emsley@epfl.ch.
  • Cordova M; Data Science & Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, 43183 Gothenburg, Sweden.
  • Pinon AC; Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. lyndon.emsley@epfl.ch.
  • Grohe K; National Centre for Computational Design and Discovery of Novel Materials MARVEL, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Wegner S; Swedish NMR Center, Department of Chemistry and Molecular Biology, University of Gothenburg, 41390 Gothenburg, Sweden.
  • Putra OD; Bruker BioSpin GmbH & Co KG, 76275 Ettlingen, Germany.
  • Norberg S; Bruker BioSpin GmbH & Co KG, 76275 Ettlingen, Germany.
  • Welinder A; Early Product Development and Manufacturing, Pharmaceutical Sciences, R&D, AstraZeneca, 43183 Gothenburg, Sweden.
  • Schantz S; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 43183 Gothenburg, Sweden.
  • Emsley L; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 43183 Gothenburg, Sweden.
Faraday Discuss ; 2024 Sep 19.
Article em En | MEDLINE | ID: mdl-39297322
ABSTRACT
The recent development of ultra-fast magic-angle spinning (MAS) (>100 kHz) provides new opportunities for structural characterization in solids. Here, we use NMR crystallography to validate the structure of verinurad, a microcrystalline active pharmaceutical ingredient. To do this, we take advantage of 1H resolution improvement at ultra-fast MAS and use solely 1H-detected experiments and machine learning methods to assign all the experimental proton and carbon chemical shifts. This framework provides a new tool for elucidating chemical information from crystalline samples with limited sample volume and yields remarkably faster acquisition times compared to 13C-detected experiments, without the need to employ dynamic nuclear polarization.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Faraday Discuss Assunto da revista: QUIMICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Faraday Discuss Assunto da revista: QUIMICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça